David R. Sell

8.4k total citations · 1 hit paper
81 papers, 6.4k citations indexed

About

David R. Sell is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, David R. Sell has authored 81 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Clinical Biochemistry, 25 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Physiology. Recurrent topics in David R. Sell's work include Advanced Glycation End Products research (56 papers), Biochemical effects in animals (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). David R. Sell is often cited by papers focused on Advanced Glycation End Products research (56 papers), Biochemical effects in animals (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). David R. Sell collaborates with scholars based in United States, United Kingdom and Norway. David R. Sell's co-authors include Vincent M. Monnier, Saul Genuth, Patrizio Odetti, Patricia A. Cleary, John Fogarty, Christopher Strauch, William T. Dahms, Ramanakoppa H. Nagaraj, Wanjie Sun and John M. Lachin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David R. Sell

81 papers receiving 6.3k citations

Hit Papers

Structure Elucidation of a Senescence Cross-Link from Hum... 1989 2026 2001 2013 1989 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Sell United States 40 3.9k 2.1k 1.3k 1.2k 753 81 6.4k
Rong Cao China 28 2.2k 0.6× 974 0.5× 1.5k 1.1× 786 0.6× 332 0.4× 95 4.8k
Joaquı́n Arenas Spain 48 1.9k 0.5× 479 0.2× 4.7k 3.6× 1.5k 1.2× 265 0.4× 307 8.9k
Hiroshi Uchino Japan 29 610 0.2× 965 0.5× 1.9k 1.5× 660 0.5× 177 0.2× 115 5.2k
Wolfgang Herrmann Germany 51 698 0.2× 415 0.2× 1.6k 1.2× 1.6k 1.3× 290 0.4× 206 8.0k
Daniela Weber Germany 35 653 0.2× 543 0.3× 1.7k 1.3× 1.2k 1.0× 282 0.4× 90 5.3k
Darren J. Kelly Australia 64 880 0.2× 1.9k 0.9× 3.5k 2.7× 930 0.7× 543 0.7× 234 11.0k
Claudia Miele Italy 38 515 0.1× 982 0.5× 2.8k 2.1× 1.8k 1.4× 214 0.3× 123 6.4k
Francesco Bèguinot Italy 49 522 0.1× 1.3k 0.6× 4.2k 3.3× 2.2k 1.8× 271 0.4× 200 9.2k
Ryoichi Takayanagi Japan 57 444 0.1× 2.5k 1.2× 4.7k 3.7× 1.4k 1.2× 855 1.1× 312 12.4k
Lin Lu China 36 551 0.1× 735 0.3× 1.6k 1.2× 406 0.3× 267 0.4× 191 4.8k

Countries citing papers authored by David R. Sell

Since Specialization
Citations

This map shows the geographic impact of David R. Sell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Sell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Sell more than expected).

Fields of papers citing papers by David R. Sell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Sell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Sell. The network helps show where David R. Sell may publish in the future.

Co-authorship network of co-authors of David R. Sell

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Sell. A scholar is included among the top collaborators of David R. Sell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Sell. David R. Sell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Islam, Sidra, Grant L. Hom, Samuel Wheeler, et al.. (2022). α-Crystallin chaperone mimetic drugs inhibit lens γ-crystallin aggregation: Potential role for cataract prevention. Journal of Biological Chemistry. 298(10). 102417–102417. 8 indexed citations
2.
Sell, David R., Wanjie Sun, Xiaoyu Gao, et al.. (2016). Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes. Cardiovascular Diabetology. 15(1). 30–30. 21 indexed citations
3.
Monnier, Vincent M., Wanjie Sun, Xiaoyu Gao, et al.. (2015). Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovascular Diabetology. 14(1). 118–118. 51 indexed citations
4.
Gosker, Harry R., et al.. (2015). Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 992–1000. 16 indexed citations
5.
Fessel, Gion, Yufei Li, Manuel Guizar‐Sicairos, et al.. (2014). Advanced Glycation End-Products Reduce Collagen Molecular Sliding to Affect Collagen Fibril Damage Mechanisms but Not Stiffness. PLoS ONE. 9(11). e110948–e110948. 113 indexed citations
6.
Monnier, Vincent M., Wanjie Sun, David R. Sell, et al.. (2013). Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clinical Chemistry and Laboratory Medicine (CCLM). 52(1). 21–32. 57 indexed citations
7.
Juneja, Subhash C., Alin Vonica, Caroline J. Zeiss, et al.. (2013). Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia. Bone. 60. 148–161. 17 indexed citations
8.
Monnier, Vincent M. & David R. Sell. (2006). Prevention and Repair of Protein Damage by the Maillard Reaction In Vivo. Rejuvenation Research. 9(2). 264–273. 51 indexed citations
9.
Sell, David R., Klaus M. Biemel, Oliver Reihl, et al.. (2005). Glucosepane Is a Major Protein Cross-link of the Senescent Human Extracellular Matrix. Journal of Biological Chemistry. 280(13). 12310–12315. 170 indexed citations
10.
Sell, David R. & Vincent M. Monnier. (2004). Conversion of Arginine into Ornithine by Advanced Glycation in Senescent Human Collagen and Lens Crystallins. Journal of Biological Chemistry. 279(52). 54173–54184. 52 indexed citations
11.
Sell, David R., Mark A. Lane, Mark E. Obrenovich, et al.. (2003). The Effect of Caloric Restriction on Glycation and Glycoxidation in Skin Collagen of Nonhuman Primates. The Journals of Gerontology Series A. 58(6). B508–B516. 42 indexed citations
12.
Sell, David R., James F. Nelson, & Vincent M. Monnier. (2001). Effect of Chronic Aminoguanidine Treatment on Age-Related Glycation, Glycoxidation, and Collagen Cross-linking in the Fischer 344 Rat. The Journals of Gerontology Series A. 56(9). B405–B411. 41 indexed citations
13.
Frank, Adrian, David R. Sell, Rolf Danielsson, John Fogarty, & Vincent M. Monnier. (2000). A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden. The Science of The Total Environment. 249(1-3). 123–131. 19 indexed citations
14.
Sell, David R.. (1997). Ageing promotes the increase of early glycation Amadori product as assessed by ϵ-N-(2-furoylmethyl)-l-lysine (furosine) levels in rodent skin collagen. Mechanisms of Ageing and Development. 95(1-2). 81–99. 32 indexed citations
15.
Monnier, Vincent M., Ram H. Nagaraj, Manuel Portero-Otı́n, et al.. (1996). Structure of advanced Maillard reaction products and their pathological role. Nephrology Dialysis Transplantation. 11(supp5). 20–26. 64 indexed citations
16.
Monnier, Vincent M., David R. Sell, Ramanakoppa H. Nagaraj, & Satoshi Miyata. (1991). Mechanisms of Protection against Damage Mediated by the Maillard Reaction in Aging. Gerontology. 37(1-3). 152–165. 62 indexed citations
17.
Sell, David R., Ramanakoppa H. Nagaraj, Patrizio Odetti, et al.. (1991). Pentosidine: A molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes/Metabolism Reviews. 7(4). 239–251. 145 indexed citations
18.
Sell, David R. & Vincent M. Monnier. (1990). End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen.. Journal of Clinical Investigation. 85(2). 380–384. 239 indexed citations
19.
Sell, David R., et al.. (1985). Mucin excretion and morphology of the intestinal tract as influenced by sorghum tannins. Nutrition reports international. 31(6). 1369–1374. 39 indexed citations
20.
Rogler, J.C. & David R. Sell. (1984). Effects of stage of maturity on the tannin content and nutritional quality of low and high tannin sorghum. Nutrition reports international. 29(6). 1281–1287. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026